Survivin Variants in Gastric Cancer
Author Information
Author(s): Krieg A, Mahotka C, Krieg T, Grabsch H, Müller W, Takeno S, Suschek C V, Heydthausen M, Gabbert H E, Gerharz C D
Primary Institution: Heinrich Heine-University
Hypothesis
The study investigates the expression of different survivin variants in gastric carcinomas and their potential role in tumor progression.
Conclusion
The study demonstrates that survivin-2B expression decreases in advanced stages of gastric cancer, suggesting its role in tumor progression.
Supporting Evidence
- All gastric carcinomas express survivin-ΔEx3, survivin-2B, and survivin, with survivin being the dominant transcript.
- Survivin-2B expression significantly decreases in advanced stages of gastric cancer.
- Survivin expression is found in all major histological types of gastric carcinomas.
Takeaway
This study looked at how different forms of a protein called survivin behave in stomach cancer, finding that one form, survivin-2B, decreases as the cancer gets worse.
Methodology
Quantitative reverse transcriptase polymerase chain reaction (RT-PCR) was performed on RNA samples from 30 gastric carcinomas to analyze survivin variant expression.
Limitations
The study could not analyze survivin-2B and survivin-ΔEx3 protein levels due to the lack of specific antibodies.
Participant Demographics
Patients who underwent gastrectomy for gastric carcinoma.
Statistical Information
P-Value
0.033
Statistical Significance
p=0.033
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website